Moustafa E El-Araby
Biochemistry — King Abdulaziz University, Saudi Arabia
Moustafa E El-Araby
LeadR Profile
Biochemistry
Subspecialties: Hematology - Pharmacy - Oncology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2009 - 2025
Number : 40
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Michael Acceptor Compounds as Hemoglobin Oxygen Affinity Modulators for Reversing Sickling of Red Blood Cells. cells, genes, hemoglobins, erythrocytes, blood, polymers, anemia, sickle cell, globins, blood cells, therapeutics | Pharmaceuticals (Basel) | 2025 | 0 |
| Exploring a kinase inhibitor targeting PI3KCA mutant cancer cells. cells, breast neoplasms, molecular biology, neoplasms, cell line, breast, therapeutics | J Biomol Struct Dyn | 2025 | 0 |
| Integrating transcriptomics with disease-gene network and identification of EGFR kinase target: inhibitor discovery through virtual screening of natural compounds for brain cancer therapy. brain neoplasms, genes, gene regulatory networks, molecular biology, brain, neoplasms, therapeutics, small molecules | J Biomol Struct Dyn | 2025 | 0 |
| Synthesis, molecular modelling, and biological evaluation of novel quinoxaline derivatives for treating type II diabetes. diabetes mellitus, enzyme inhibitors, pharmaceutical preparations, glucosidases, coronary disease, therapeutics, quinoxalines, phospholipases a2, secretory, diabetes complications | J Enzyme Inhib Med Chem | 2024 | 0 |
| Computational insights into the stereo-selectivity of catechins for the inhibition of the cancer therapeutic target EGFR kinase. growth, membranes, pharmaceutical preparations, therapeutics, neoplasms, catechin | Front Pharmacol | 2024 | 3 |
LeadR Networks
Main global connection map